EN
Naringenin, Helichrysin A: Characterization, isolation, molecular docking studies and enzyme inhibitory profiles for carbonic anhydrase, acetylcholinesterase, and α-glycosidase
Abstract
In the current study, Naringenin and Helichrysin A purified and characterized from Helichrysum plicatum subsp. pseudoplicatum. The inhibitory effects of isolated Naringenin and Helichrysin A were tested against human carbonic anhydrase I (hCA I) and II isoenzymes (hCA II), α-glycosidase (α-gly) and acetylcholinesterase (AChE). Naringenin and Helichrysin A’s Ki values were found to respectively 51.99±2.78 and 75.75±13.66 nM against hCA I, 36.16±2.02 and 96.81±12.46 nM against hCA II, 0.74±0.04 and 1.27±0.16 nM against AChE, 8.34±1.61 and 9.58±1.90 nM against α-gly. As a result, the inhibitory effects of the isolated compounds against each metabolic enzyme examined were demonstrated. Moreover, in the molecular docking study of Helichrysin A, it was observed that the three enzymes had the lowest binding free energy and maximum binding affinity. Helichrysin A and Naringenin show promise as treatments for conditions including epilepsy, leukemia, diabetes mellitus, glaucoma, and Alzheimer's disease.
Keywords
References
- [1] Erbaş S, Erdoğan Ü, Mutlucan M. The Scent compounds of immortelle ecotypes (Helichrysum italicum (Roth) G. Don.) grown in Türkiye and its new products (absolute and concrete). S Afr J Bot. 2023; 158: 301-311. https://doi.org/10.1016/j.sajb.2023.05.029
- [2] Albayrak S, Aksoy A, Sagdic O, Hamzaoglu E. Compositions, antioxidant and antimicrobial activities of Helichrysum (Asteraceae) species collected from Turkey. Food Chem. 2010; 119 (1): 114-122. https://doi.org/10.1016/j.foodchem.2009.06.003
- [3] Vural A. Gold and silver content of plant Helichrysum arenarium, popularly known as the golden flower, growing in Gümüşhane, NE Turkey. Acta Phys Pol A. 2017; 132 (3): 978-980. https://doi.org/10.12693/APhysPolA.132.978
- [4] Antunes Viegas D, Palmeira-de-Oliveira A, Salgueiro L, Martinez-de-Oliveira J, Palmeira-de-Oliveira R. Helichrysum italicum: From traditional use to scientific data. J Ethnopharmacol. 2014; 151 (1): 54-65. https://doi.org/10.1016/j.jep.2013.11.005
- [5] Pljevljakušić D, Bigović D, Janković T, Jelačić S, Šavikin K. Sandy everlasting (Helichrysum arenarium (L.) Moench): Botanical, chemical and biological properties. Front Plant Sci. 2018; 9: 1123. https://doi.org/10.3389/fpls.2018.01123
- [6] Akaberi M, Sahebkar A, Azizi N, Emami SA. Everlasting flowers: Phytochemistry and pharmacology of the genus Helichrysum. Ind Crops Prod. 2019; 138. https://doi.org/10.1016/j.indcrop.2019.111471
- [7] Maksimovic S, Tadic V, Skala D, Zizovic I. Separation of phytochemicals from Helichrysum italicum: An analysis of different isolation techniques and biological activity of prepared extracts. Phytochemistry. 2017; 138: 9-28. https://doi.org/10.1016/j.phytochem.2017.01.001
- [8] Süntar I, Küpeli Akkol E, Keles H, Yesilada E, Sarker SD. Exploration of the wound healing potential of Helichrysum graveolens (Bieb.) Sweet: Isolation of apigenin as an active component. J Ethnopharmacol. 2013; 149 (1): 103-110. https://doi.org/10.1016/j.jep.2013.06.006
Details
Primary Language
English
Subjects
Pharmaceutical Botany
Journal Section
Research Article
Publication Date
June 4, 2025
Submission Date
February 6, 2024
Acceptance Date
March 14, 2024
Published in Issue
Year 2025 Volume: 29 Number: 3
APA
Güven, L., Ertürk, A., & Gülçin, İ. (2025). Naringenin, Helichrysin A: Characterization, isolation, molecular docking studies and enzyme inhibitory profiles for carbonic anhydrase, acetylcholinesterase, and α-glycosidase. Journal of Research in Pharmacy, 29(3), 1198-1208. https://doi.org/10.12991/jrespharm.1694383
AMA
1.Güven L, Ertürk A, Gülçin İ. Naringenin, Helichrysin A: Characterization, isolation, molecular docking studies and enzyme inhibitory profiles for carbonic anhydrase, acetylcholinesterase, and α-glycosidase. J. Res. Pharm. 2025;29(3):1198-1208. doi:10.12991/jrespharm.1694383
Chicago
Güven, Leyla, Adem Ertürk, and İlhami Gülçin. 2025. “Naringenin, Helichrysin A: Characterization, Isolation, Molecular Docking Studies and Enzyme Inhibitory Profiles for Carbonic Anhydrase, Acetylcholinesterase, and α-Glycosidase”. Journal of Research in Pharmacy 29 (3): 1198-1208. https://doi.org/10.12991/jrespharm.1694383.
EndNote
Güven L, Ertürk A, Gülçin İ (June 1, 2025) Naringenin, Helichrysin A: Characterization, isolation, molecular docking studies and enzyme inhibitory profiles for carbonic anhydrase, acetylcholinesterase, and α-glycosidase. Journal of Research in Pharmacy 29 3 1198–1208.
IEEE
[1]L. Güven, A. Ertürk, and İ. Gülçin, “Naringenin, Helichrysin A: Characterization, isolation, molecular docking studies and enzyme inhibitory profiles for carbonic anhydrase, acetylcholinesterase, and α-glycosidase”, J. Res. Pharm., vol. 29, no. 3, pp. 1198–1208, June 2025, doi: 10.12991/jrespharm.1694383.
ISNAD
Güven, Leyla - Ertürk, Adem - Gülçin, İlhami. “Naringenin, Helichrysin A: Characterization, Isolation, Molecular Docking Studies and Enzyme Inhibitory Profiles for Carbonic Anhydrase, Acetylcholinesterase, and α-Glycosidase”. Journal of Research in Pharmacy 29/3 (June 1, 2025): 1198-1208. https://doi.org/10.12991/jrespharm.1694383.
JAMA
1.Güven L, Ertürk A, Gülçin İ. Naringenin, Helichrysin A: Characterization, isolation, molecular docking studies and enzyme inhibitory profiles for carbonic anhydrase, acetylcholinesterase, and α-glycosidase. J. Res. Pharm. 2025;29:1198–1208.
MLA
Güven, Leyla, et al. “Naringenin, Helichrysin A: Characterization, Isolation, Molecular Docking Studies and Enzyme Inhibitory Profiles for Carbonic Anhydrase, Acetylcholinesterase, and α-Glycosidase”. Journal of Research in Pharmacy, vol. 29, no. 3, June 2025, pp. 1198-0, doi:10.12991/jrespharm.1694383.
Vancouver
1.Leyla Güven, Adem Ertürk, İlhami Gülçin. Naringenin, Helichrysin A: Characterization, isolation, molecular docking studies and enzyme inhibitory profiles for carbonic anhydrase, acetylcholinesterase, and α-glycosidase. J. Res. Pharm. 2025 Jun. 1;29(3):1198-20. doi:10.12991/jrespharm.1694383